News|Articles|August 11, 2008

New products bring lice treatment to a head

It has been 22 years since the Food and Drug Administration approved a new prescription drug treatment for head lice, but now several new remedies are on the horizon.

What's in the future

More information on lice and the misconceptions surrounding them can be found under Web Exclusives on http://www.drugtopics.com.

THE AUTHOR is a writer based in New Hampshire.

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

New products bring lice treatment to a head

Related Content

Functional Somatic Disorder Doesn’t Explain Quality of Life in Long COVID

Serotype 4 IPD Threat for Young Adults, Unvaccinated Men

Long-Term Glucose-Lowering Therapy Lowers Cardiovascular Risk in Diabetes

Pandemic-Era Household Stress Hit Nearly Half of Pregnant Women

Updated COVID-19 Vaccines Effectively Protect Against Symptomatic Infection

Latest CME

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies

The Pharmacist's Role in Palliative and End of Life Symptom Management (Pharmacy Technician Credit)

The Pharmacist's Role in Palliative and End of Life Symptom Management

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians (Pharmacy Technician Credit)

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

Exploring Oncolytic Viruses in Melanoma: Pharmacist-Led Approaches for Safe Integration

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

Trending on Drug Topics

Functional Somatic Disorder Doesn’t Explain Quality of Life in Long COVID

Updated COVID-19 Vaccines Effectively Protect Against Symptomatic Infection

Long-Term Glucose-Lowering Therapy Lowers Cardiovascular Risk in Diabetes

Serotype 4 IPD Threat for Young Adults, Unvaccinated Men

Gastrointestinal Effects of GLP-1 Drive Discontinuation for Nondiabetic Adults